Showing results (91-100 of 145) with videos related to
Sort By:
Pageof 15
Journal of Virology|June 4, 2010
An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza virusesHsueh-Ling Janice Oh, Sara Akerström, Shuo Shen, et al.Virology Journal|June 21, 2005
Genetic lesions within the 3a gene of SARS-CoVTimothy H P Tan, Timothy Barkham, Burtram C Fielding, et al.Virus Research|August 14, 2016
Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding abilityYuqi Huo, Wenhui Wang, Tong Ling, et al.BMC Cancer|May 26, 2021
Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinomaBo Li, Shuo Shen, Siting You, et al.British Journal of Cancer|January 24, 2020
Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patientsShiwei Guo, Xiaohan Shi, Jing Shen, et al.Journal of Virology|July 5, 2002
Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infectionAmanda D Stuart, Thomas A McKee, Pamela A Williams, et al.Viruses|October 28, 2023
Identification of Critical Amino Acids of Coxsackievirus A10 Associated with Cell Tropism and Viral RNA Release during UncoatingJie Pei, Rui-Lun Liu, Zhi-Hui Yang, et al.Emerging Microbes & Infections|November 14, 2022
Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in miceHuan-Huan An, Meng Li, Rui-Lun Liu, et al.Emerging Microbes & Infections|March 19, 2021
Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse modelSha-Sha Qian, Zhen-Ni Wei, Wei-Ping Jin, et al.Microbial Pathogenesis|December 3, 2020
Amino acid substitutions in VP2, VP1, and 2C attenuate a Coxsackievirus A16 in miceGaobo Zhang, Bing Hu, Yuqi Huo, et al.Pageof 15